Literature DB >> 6726888

Characterization of saturable binding sites for rabies virus.

W H Wunner, K J Reagan, H Koprowski.   

Abstract

A specific, saturable receptor for rabies virus was analyzed on cultured cells of neural or non-neural origin. Viral attachment kinetics were enhanced by DEAE-dextran, an effect which in turn enhanced the apparent infectivity of the virus inoculum. Under optimized conditions, the attachment of metabolically labeled ERA strain rabies virus obeyed the laws of mass action, whereby the amount of virus bound to cells varied proportionally with the concentration of cells or virus. Attachment was sensitive to changes of temperature and pH, did not require divalent cations such as Mg2+ or Ca2+, and occurred despite prior treatment of cells with proteolytic or sialic acid-specific enzymes. Saturation of the cell surface with rabies virus could be accomplished with 3 X 10(3) to 15 X 10(3) attached virions per cell. Competition for the rabies receptor occurred with rabies nonpathogenic variant virus, RV194 -2, and vesicular stomatitis virus. Reovirus type 3, another neurotropic virus, failed to inhibit rabies virus binding, and West Nile virus only slightly inhibited rabies virus binding, suggesting independent cellular receptors were recognized by these viruses. Isolated rabies virus glycoprotein failed to compete in an equivalent manner. However, solubilization of BHK-21 cells with octylglucoside yielded a chloroform-methanol-soluble extract which blocked rabies virus attachment. The binding inhibition activity of this extract was resistant to proteases but could be destroyed by phospholipases and neuraminidase, suggesting a phospholipid or glycolipid component at the receptor site. These data provide evidence for a rhabdovirus-common mechanism for cellular attachment to cells in culture.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6726888      PMCID: PMC255726          DOI: 10.1128/JVI.50.3.691-697.1984

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Unrelated animal viruses share receptors.

Authors:  K Lonberg-Holm; R L Crowell; L Philipson
Journal:  Nature       Date:  1976-02-26       Impact factor: 49.962

2.  Rabies pathogenesis.

Authors:  F A Murphy
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

3.  Specific binding sites for a parvovirus, minute virus of mice, on cultured mouse cells.

Authors:  P Linser; H Bruning; R W Armentrout
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

4.  Early events of rabies virus replicaton in tissue cultures. An electron microscopic study.

Authors:  Y Iwasaki; T J Wiktor; H Koprowski
Journal:  Lab Invest       Date:  1973-02       Impact factor: 5.662

5.  Early interaction of rhinoviruses with host cells.

Authors:  K Lonberg-Holm; B D Korant
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

6.  Induction and biological properties of defective interfering particles of rabies virus.

Authors:  T J Wiktor; B Dietzschold; R N Leamnson; H Koprowski
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

7.  Isolation and purification of a polymeric form of the glycoprotein of rabies virus.

Authors:  B Dietzschold; J H Cox; L G Schneider; T J Wiktor; H Koprowski
Journal:  J Gen Virol       Date:  1978-07       Impact factor: 3.891

8.  Hemolysis and cell fusion by rhabdoviruses.

Authors:  K Mifune; M Ohuchi; K Mannen
Journal:  FEBS Lett       Date:  1982-01-25       Impact factor: 4.124

Review 9.  Early interaction between animal viruses and cells.

Authors:  K Lonberg-Holm; L Philipson
Journal:  Monogr Virol       Date:  1974

10.  Virus-receptor interaction in an adenovirus system.

Authors:  L Philipson; K Lonberg-Holm; U Pettersson
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

View more
  44 in total

1.  Fish rhabdovirus cell entry is mediated by fibronectin.

Authors:  M Bearzotti; B Delmas; A Lamoureux; A M Loustau; S Chilmonczyk; M Bremont
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Molecular characterization of viral G gene in emerging and re-emerging areas of rabies in China, 2007 to 2011.

Authors:  Shu-Lin Lang; Xiao-Yan Tao; Zhen-Yang Guo; Qing Tang; Hao Li; Cui-Ping Yin; Ying Li; Guo-Dong Liang
Journal:  Virol Sin       Date:  2012-06-09       Impact factor: 4.327

3.  Development and evaluation of an in vitro virus isolation procedure as a replacement for the mouse inoculation test in rabies diagnosis.

Authors:  R J Rudd; C V Trimarchi
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

4.  Identification and Characterization of a Small-Molecule Rabies Virus Entry Inhibitor.

Authors:  Venice Du Pont; Christoph Wirblich; Jeong-Joong Yoon; Robert M Cox; Matthias J Schnell; Richard K Plemper
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

5.  Reversible conformational changes and fusion activity of rabies virus glycoprotein.

Authors:  Y Gaudin; C Tuffereau; D Segretain; M Knossow; A Flamand
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

6.  Characterization of protein involvement in rabies virus binding to BHK-21 cells.

Authors:  J H Broughan; W H Wunner
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

7.  General analysis of receptor-mediated viral attachment to cell surfaces.

Authors:  T J Wickham; R R Granados; H A Wood; D A Hammer; M L Shuler
Journal:  Biophys J       Date:  1990-12       Impact factor: 4.033

8.  An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro.

Authors:  P Coulon; J P Ternaux; A Flamand; C Tuffereau
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

9.  Identification of amino acids controlling the low-pH-induced conformational change of rabies virus glycoprotein.

Authors:  Y Gaudin; H Raux; A Flamand; R W Ruigrok
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 10.  Superantigen related to rabies.

Authors:  M Lafon; A Galelli
Journal:  Springer Semin Immunopathol       Date:  1996
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.